Phase 3 Readout~month

Phase 3 Topline: A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children

Indication
Hereditary Angioedema; Pediatric

Other upcoming events for BCRX

Patent ExpiryPatent/Exclusivity Expiry: SPRYCEL
Patent ExpiryPatent/Exclusivity Expiry: XALKORI
Patent ExpiryPatent/Exclusivity Expiry: GILOTRIF
Patent ExpiryPatent/Exclusivity Expiry: ALIQOPA
Patent ExpiryPatent/Exclusivity Expiry: TRUQAP

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children — BCRX Phase 3 Readout | BioSniper